ArticleHernia : the journal of hernias and abdominal wall surgery2025
Effectiveness of topical gentamicin in preventing surgical site infections during hernia mesh repair: experience from developing countries.
Article in Hernia : the journal of hernias and abdominal wall surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond acronyms: a domain-based structural analysis of abdominal wall hernia repair techniques in the contemporary literature.Surgical endoscopy · 2026Article
- Reinforcement mesh repair for persistent pleural leakage following VATS lobectomy: a case report and clinical insights.Journal of cardiothoracic surgery · 2026Article
- How Reproducible Are Abdominal Wall Surgical Techniques? A Methodological Assessment of Technical Reporting in the Contemporary Literature.Journal of abdominal wall surgery : JAWS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecently, mesh repair has become a standard treatment for inguinal and ventral hernial disease worldwide. Consequently, mesh-related complications have increased, especially superficial site infections. This study aimed to determine the role of topical gentamicin in reducing superficial surgical site infection.
methodsThis was a prospective, cross-sectional, comparative, hospital-based study conducted between July 2022 and March 2023. Patients who underwent elective mesh repair for inguinal or para-umbilical hernia were reviewed. Participants were divided into two groups: the control group (G1), which did not receive topical gentamicin, and the study group (G2), which received topical gentamicin. The surgical site was examined on the 1st, 7th, and 30th postoperative days for signs of infection according to the definitions provided by the Centers for Disease Control Control.
resultsA total of 197 fulfilled our inclusion criteria. The infection rate in all study participants (N = 197) was 4.5%. A total of (n = 9) 4.5% SSIs occurred among the 197 patients, with 3.5% (n = 7) in G1 and 1% (n = 2) in G2 (Table 2). Four patients (2.0%) developed a hematoma, all of whom had an inguinal hernia. Three of these patients developed SSI, with two in G1 and one in G2 All infections observed were superficial surgical infections (SSI); No statistical significance was ruled out.
conclusionOur study sheds light on the use of topical gentamicin in preventing early SSIs following hernia and para-umbilical mesh repair surgery in developing countries. There are no significant differences when using topical gentamicin to prevent surgical site infections.
Indexed as
Identifiers
40407916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.